The Hain Celestial Group, Inc. (HAIN) Stock Analysis

Hain is a distressed health-and-wellness packaged-food company undergoing a fundamental portfolio reset. After selling its North American snacks business in March 2026, it agreed on September 14, 2026 to sell most of International to Aurelius for approximately $323 million, creating a focused North American pure-play built around Celestial Seasonings, The Greek Gods and Earth’s Best. **The central investment case is balance-sheet repair:** $305-$310 million of net proceeds are intended to repay the entire term loan and reduce the revolver by more than 35%, cutting total debt by roughly 55%. FY2026 reported revenue fell 13% to $1.35 billion and GAAP loss was $304.9 million, but operating cash flow reached $78.3 million and free cash flow $57.7 million. Q4 North American organic sales returned to growth, while adjusted gross margin expanded to roughly 31% and adjusted EBITDA margin reached 14.4%. **The key catalyst is refinancing and transaction completion before the December 22, 2026 maturity.** At a $0.65 reference price, $55.9 million market capitalization and 0.26x P/B, upside is substantial if the company achieves 30%+ gross margins and low-double-digit EBITDA margins; however, failure could produce delisting, restructuring or bankruptcy.